MYC and metabolism on the path to cancer

被引：258

作者：

Hsieh, Annie L. ^{[1
,2
,3
]}

Walton, Zandra E. ^{[1
,2
]}

Altman, Brian J. ^{[1
,2
]}

Stine, Zachary E. ^{[1
,2
]}

Dang, Chi V. ^{[1
,2
,4
]}

机构：

[1] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA

[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA

[4] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA

来源：

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY | 2015年 / 43卷

基金：

美国国家卫生研究院;

关键词：

Myc; Metabolism; Cancer; mTOR; INITIATION-FACTOR; 4E; FATTY-ACID SYNTHESIS; C-MYC; GLUTAMINE-METABOLISM; TRANSLATION INITIATION; TRANSCRIPTION FACTOR; PROTEIN-SYNTHESIS; BURKITT-LYMPHOMA; DROSOPHILA-MYC; UP-REGULATION;

D O I：

10.1016/j.semcdb.2015.08.003

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The MYC proto-oncogene is frequently deregulated in human cancers, activating genetic programs that orchestrate biological processes to promote growth and proliferation. Altered metabolism characterized by heightened nutrients uptake, enhanced glycolysis and glutaminolysis and elevated fatty acid and nucleotide synthesis is the hallmark of MYC-driven cancer. Recent evidence strongly suggests that Mycdependent metabolic reprogramming is critical for tumorigenesis, which could be attenuated by targeting specific metabolic pathways using small drug-like molecules. Understanding the complexity of MYCmediated metabolic re-wiring in cancers as well as how MYC cooperates with other metabolic drivers such as mammalian target of rapamycin (mTOR) will provide translational opportunities for cancer therapy. (C) 2015 Published by Elsevier Ltd.

引用

页码：11 / 21

页数：11

共 50 条

[21] MYC as a target for cancer treatment
Duffy, Michael J.
O'Grady, Shane
Tang, Minhong
Crown, John
CANCER TREATMENT REVIEWS, 2021, 94
[22] Links between metabolism and cancer
Dang, Chi V.
GENES & DEVELOPMENT, 2012, 26 (09) : 877 - 890
[23] Hypoxia and cancer cell metabolism
Huang, De
Li, Chenchen
Zhang, Huafeng
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2014, 46 (03) : 214 - 219
[24] MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
Tambay, Vincent
Raymond, Valerie-Ann
Bilodeau, Marc
CANCERS, 2021, 13 (17)
[25] Exploring MYC relevance to cancer biology from the perspective of cell competition
Paglia, Simona
Sollazzo, Manuela
Di Giacomo, Simone
Strocchi, Silvia
Grifoni, Daniela
SEMINARS IN CANCER BIOLOGY, 2020, 63 : 49 - 59
[26] The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis
Carroll, Patrick A.
Freie, Brian W.
Mathsyaraja, Haritha
Eisenman, Robert N.
FRONTIERS OF MEDICINE, 2018, 12 (04) : 412 - 425
[27] MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells
Altman, Brian J.
Hsieh, Annie L.
Sengupta, Arjun
Krishnanaiah, Saikumari Y.
Stine, Zachary E.
Walton, Zandra E.
Gouw, Arvin M.
Venkataraman, Anand
Li, Bo
Goraksha-Hicks, Pankuri
Diskin, Sharon J.
Bellovin, David I.
Simon, M. Celeste
Rathmell, Jeffrey C.
Lazar, Mitchell A.
Maris, John M.
Felsher, Dean W.
Hogenesch, John B.
Weljie, Aalim M.
Dang, Chi V.
CELL METABOLISM, 2015, 22 (06) : 1009 - 1019
[28] The emerging roles of microRNAs in cancer metabolism
Chan, Brian
Manley, Jacob
Lee, Jae
Singh, Shree Ram
CANCER LETTERS, 2015, 356 (02) : 301 - 308
[29] Drosophila Myc: A master regulator of cellular performance
Grifoni, Daniela
Bellosta, Paola
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2015, 1849 (05): : 570 - 581
[30] Polycomb group proteins and MYC: the cancer connection
Benetatos, Leonidas
Vartholomatos, George
Hatzimichael, Eleftheria
CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (02) : 257 - 269

← 1 2 3 4 5 →